Clinical

Dataset Information

0

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

ABSTRACT: This phase IIA trial investigates the side effects of Ad5.F35-hGCC-PADRE vaccine and to see how well it works in treating patients with gastrointestinal adenocarcinoma. Ad5.F35-hGCC-PADRE vaccine may help to train the patient’s own immune system to identify and kill tumor cells and prevent it from coming back.

DISEASE(S): Adenocarcinoma,Stage Iva Colorectal Cancer Ajcc V8,Colorectal Adenocarcinoma,Gastrointestinal Neoplasms,Gastric Adenocarcinoma,Stage Iib Pancreatic Cancer Ajcc V8,Clinical Stage Ii Gastric Cancer Ajcc V8,Pathologic Stage Iib Gastric Cancer Ajcc V8,Pathologic Stage Iii Gastric Cancer Ajcc V8,Pathologic Stage Iii Esophageal Adenocarcinoma Ajcc V8,Stage Iiic Colorectal Cancer Ajcc V8,Neoplasms,Pancreatic Ductal Adenocarcinoma,Stage Ivb Colorectal Cancer Ajcc V8,Pathologic Stage Iib Esophageal Adenocarcinoma Ajcc V8,Pathologic Stage Iiia Esophageal Adenocarcinoma Ajcc V8,Esophageal Neoplasms,Stage Iii Pancreatic Cancer Ajcc V8,Small Intestinal Adenocarcinoma,Stage Iia Pancreatic Cancer Ajcc V8,Colorectal Neoplasms,Malignant Solid Neoplasm,Clinical Stage Iii Gastric Cancer Ajcc V8,Stage Ia Pancreatic Cancer Ajcc V8,Pancreatic Neoplasms,Stomach Neoplasms,Pathologic Stage Iiia Gastric Cancer Ajcc V8,Clinical Stage Iia Gastric Cancer Ajcc V8,Digestive System Neoplasms,Stage Iiib Colorectal Cancer Ajcc V8,Pathologic Stage Iiic Gastric Cancer Ajcc V8,Stage Iv Colorectal Cancer Ajcc V8,Stage Ib Pancreatic Cancer Ajcc V8,Malignant Digestive System Neoplasm,Clinical Stage Iii Esophageal Adenocarcinoma Ajcc V8,Stage Iiia Colorectal Cancer Ajcc V8,Stage I Pancreatic Cancer Ajcc V8,Clinical Stage Iib Esophageal Adenocarcinoma Ajcc V8,Stage Ii Pancreatic Cancer Ajcc V8,Pathologic Stage Ii Gastric Cancer Ajcc V8,Clinical Stage Iib Gastric Cancer Ajcc V8,Stage Iiia Small Intestinal Adenocarcinoma Ajcc V8,Stage Iii Colorectal Cancer Ajcc V8,Stage Iii Small Intestinal Adenocarcinoma Ajcc V8,Pathologic Stage Iiib Gastric Cancer Ajcc V8,Pathologic Stage Iiib Esophageal Adenocarcinoma Ajcc V8

PROVIDER: 2317938 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Unknown Recurrent frameshift neoantigen vaccine elicits protective immunity with reduced tumor burden and improved overall survival in a Lynch syndrome mouse model
2021-08-30 | GSE175744 | GEO
Unknown A whole virion vaccine for COVID-19 produced via a novel inactivation method: results from animal challenge model studies
2021-02-19 | GSE165190 | GEO
Unknown mRNA and lncRNA profiling of mice spleens inoculated with group ACYW135 meningococcal polysaccharide vaccine
2023-08-30 | GSE224584 | GEO
Unknown Altered expression of PBMC miRNA profile following the third dose of inactivated COVID-19 vaccine
2024-04-01 | GSE249050 | GEO
Genomics Esophageal Adenocarcinoma
| PRJNA188928 | ENA
Genomics Lm3Dx vaccine vector
| PRJEB44087 | ENA
Proteomics Protein-based vaccine protect against Piscirickettsia salmonis in Atlantic salmon (Salmo salar)
2021-02-16 | PXD023109 | Pride
Clinical Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms
| 2268561 | ecrin-mdr-crc
Transcriptomics MYBPH, a novel transcriptional target of NKX2-1/TTF-1, inhibits ROCK1 and actomyosin assembly, and reduces cell motility and tumor metastasis
2011-12-22 | E-GEOD-26721 | biostudies-arrayexpress
Transcriptomics Transcription profiling by array of mouse dendritic cells stimulated with live influenza virus, influenza whole inactivated virus vaccine or subunit vaccine.
2015-02-13 | E-MTAB-3115 | biostudies-arrayexpress